Elin Banke1, Karin Rödström2, Mikael Ekelund3, Jonathan Dalla-Riva2, Jens O Lagerstedt2, Staffan Nilsson4, Eva Degerman2, Karin Lindkvist-Petersson2, Bo Nilson5. 1. Department of Experimental Medical Science, Lund University, BMC, 221 84 Lund, Sweden. Electronic address: elin.banke@med.lu.se. 2. Department of Experimental Medical Science, Lund University, BMC, 221 84 Lund, Sweden. 3. Department of Surgery, Skåne University Hospital & Lund University, 221 85 Lund, Sweden. 4. Pure and Applied Biochemistry, Center for Chemistry and Chemical Engineering, Lund University, 221 00 Lund, Sweden. 5. Department of Laboratory Medicine, Division of Medicinal Microbiology, Lund University, 223 62 Lund, Sweden; Department of Clinical Microbiology, University and Regional Laboratories in Region Skåne, 221 85 Lund, Sweden.
Abstract
OBJECTIVE: The bacteria Staphylococcus aureus is part of the normal bacterial flora and produces a repertoire of enterotoxins which can cause food poisoning and toxic shock and might contribute to the pathogenesis of inflammatory diseases. These enterotoxins directly cross-link the T cell receptor with MHC class II, activating large amounts of T cells and are therefore called superantigens. It was recently discovered that the superantigen SEA binds to the cytokine receptor gp130. As obesity and type 2 diabetes are highly associated with inflammation of the adipose tissue and gp130 has been shown to play an important role in adipocytes, we wanted to investigate the effect of SEA on adipocyte signaling and function. MATERIALS/ METHODS: Binding of SEA to gp130 was examined using surface plasmon resonance in a cell free system. Effects of SEA on adipocyte signaling, insulin sensitivity and function were studied using western blotting and biological assays for lipolysis, lipogenesis and glucose uptake. RESULTS: We demonstrate that SEA binds to gp130 with a medium affinity. Furthermore, SEA induces phosphorylation of a key downstream target, STAT3, in adipocytes. SEA also inhibits insulin-induced activation of PKB and PKB downstream signaling which was associated with reduced basal and insulin induced glucose uptake, reduced lipogenesis as well as reduced ability of insulin to inhibit lipolysis. CONCLUSIONS: SEA inhibits insulin signaling as well as insulin biological responses in adipocytes supporting that bacterial infection might contribute to the development of insulin resistance and type 2 diabetes.
OBJECTIVE: The bacteria Staphylococcus aureus is part of the normal bacterial flora and produces a repertoire of enterotoxins which can cause food poisoning and toxic shock and might contribute to the pathogenesis of inflammatory diseases. These enterotoxins directly cross-link the T cell receptor with MHC class II, activating large amounts of T cells and are therefore called superantigens. It was recently discovered that the superantigen SEA binds to the cytokine receptor gp130. As obesity and type 2 diabetes are highly associated with inflammation of the adipose tissue and gp130 has been shown to play an important role in adipocytes, we wanted to investigate the effect of SEA on adipocyte signaling and function. MATERIALS/ METHODS: Binding of SEA to gp130 was examined using surface plasmon resonance in a cell free system. Effects of SEA on adipocyte signaling, insulin sensitivity and function were studied using western blotting and biological assays for lipolysis, lipogenesis and glucose uptake. RESULTS: We demonstrate that SEA binds to gp130 with a medium affinity. Furthermore, SEA induces phosphorylation of a key downstream target, STAT3, in adipocytes. SEA also inhibits insulin-induced activation of PKB and PKB downstream signaling which was associated with reduced basal and insulin induced glucose uptake, reduced lipogenesis as well as reduced ability of insulin to inhibit lipolysis. CONCLUSIONS: SEA inhibits insulin signaling as well as insulin biological responses in adipocytes supporting that bacterial infection might contribute to the development of insulin resistance and type 2 diabetes.
Authors: Bao G Vu; Christopher S Stach; Katarina Kulhankova; Wilmara Salgado-Pabón; Aloysius J Klingelhutz; Patrick M Schlievert Journal: MBio Date: 2015-02-24 Impact factor: 7.867
Authors: Sofia Noli Truant; Mauricio C De Marzi; María B Sarratea; María B Antonoglou; Ana P Meo; Laura V Iannantuono López; María J Fernández Lynch; Marcos Todone; Emilio L Malchiodi; Marisa M Fernández Journal: Front Immunol Date: 2020-01-15 Impact factor: 7.561
Authors: A Hinney; M Kesselmeier; S Jall; A-L Volckmar; M Föcker; J Antel; I M Heid; T W Winkler; S F A Grant; Y Guo; A W Bergen; W Kaye; W Berrettini; H Hakonarson; B Herpertz-Dahlmann; M de Zwaan; W Herzog; S Ehrlich; S Zipfel; K M Egberts; R Adan; M Brandys; A van Elburg; V Boraska Perica; C S Franklin; M H Tschöp; E Zeggini; C M Bulik; D Collier; A Scherag; T D Müller; J Hebebrand Journal: Mol Psychiatry Date: 2016-05-17 Impact factor: 13.437
Authors: Karin E J Rödström; Paulina Regenthal; Christopher Bahl; Alex Ford; David Baker; Karin Lindkvist-Petersson Journal: Sci Rep Date: 2016-05-16 Impact factor: 4.379